Literature DB >> 4011845

Mortality in systemic lupus erythematosus: the bimodal pattern revisited.

L A Rubin, M B Urowitz, D D Gladman.   

Abstract

A review of 51 patients who died while enrolled in a long-term prospective study of systemic lupus erythematosus (SLE) revealed that active SLE may persist or reappear late in the course of the disease. Vascular events, especially atherosclerotic coronary artery disease, occurred frequently. Moderate to severe atherosclerosis was seen in patients who had died of any cause after a prolonged duration of the disease and often contributed significantly to death. Diffuse proliferative glomerulonephritis, CNS lupus and major infections were indications of poor prognosis particularly early in its course.

Entities:  

Mesh:

Year:  1985        PMID: 4011845

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  39 in total

Review 1.  Outcome and survival in systemic lupus erythematosus.

Authors:  B Bresnihan
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

2.  Survival and causes of death in patients with systemic lupus erythematosus.

Authors:  D Halberg
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

3.  Low socioeconomic status is associated with cardiovascular risk factors and outcomes in systemic lupus erythematosus.

Authors:  Janet W Maynard; Hong Fang; Michelle Petri
Journal:  J Rheumatol       Date:  2012-03-01       Impact factor: 4.666

Review 4.  Why targeted therapies are necessary for systemic lupus erythematosus.

Authors:  L Durcan; M Petri
Journal:  Lupus       Date:  2016-09       Impact factor: 2.911

5.  Antibodies to protein P in systemic lupus erythematosus.

Authors:  L S Teh; A E Bedwell; D A Isenberg; C Gordon; P Emery; P J Charles; M Harper; N Amos; B D Williams
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

Review 6.  [Changes in mortality and morbidity in systemic lupus erythematosus].

Authors:  G Chehab; R Fischer-Betz; M Schneider
Journal:  Z Rheumatol       Date:  2011-08       Impact factor: 1.372

Review 7.  Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent.

Authors:  Johannes C Grisar; Francois Haddad; Fatemeh A Gomari; Joseph C Wu
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

8.  Peripheral vascular disease in patients with systemic lupus erythematosus.

Authors:  J McDonald; J Stewart; M B Urowitz; D D Gladman
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

Review 9.  Epidemiology of atherosclerosis in systemic lupus erythematosus.

Authors:  Mandana Nikpour; Murray B Urowitz; Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

10.  Short-term perioperative all-cause mortality and cardiovascular events in women with systemic lupus erythematosus.

Authors:  Ali Yazdanyar; Mary Chester Wasko; Lisabeth V Scalzi; Kevin L Kraemer; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-06       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.